Prophylactic and therapeutic immunization

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

As we have seen, effective therapies against Helicobacter require the child to ingest multiple drugs several times a day for at least 1 week.106 The common occurrence of adverse effects (nausea, diarrhea, abdominal pain and, more rarely, pseudomembranous colitis), the frequently observed low compliance and the high costs suggest the need to evaluate different approaches.

Despite the fact that patients infected with H. pylori have a systemic and local immune response,57 this response does not resolve the infection. Studies on H. pylori-specific cellular immunity suggested that H. pylori induces a pro-inflammatory cascade and a Th1 response that contributes to the chronicity (Figure 6.2). Since 1993, several groups have developed animal models of Helicobacter infection.122 Using the mouse model, oral immunization with H. felis lysates with cholera toxin (CT) as adjuvant resulted in 76-96% of protection. Others challenged the same models using H. pylori antigens such as Vac-A, Cag-A, catalase or urease B subunit. On the basis of the results of clinical therapeutic vaccination trials, it is likely that several antigens are needed for a subunit vaccine in humans.

Several groups administered the vaccine to infected animals for therapeutic and not for prophylactic use. Oral vaccination of H. felis-infected mice with either bacterial sonicate or H. pylori urease B subunit plus CT cured approximately half of the mice. Several groups have now developed murine models of H. pylori infection. Eradication in 70-92% was achieved by using recombinant Cag-A or Vac-A as oral antigens, respectively.

Studying the H. mustelae ferret model, which represents a natural host-pathogen disease, therapeutic immunization with H. pylori urease and CT achieved eradication in one-third of ferrets.

Recently, a clinical trial tested an oral therapeutic vaccine consisting of recombinant H. pylori urease apoenzyme coupled with Escherichia coli LT in humans; a significant reduction in gastric H. pylori density was achieved along with an increase of specific IgA-producing cells.123

A different approach was based on the development of attenuated recombinant enteric pathogens expressing Helicobacter antigens. Cloning of urease A and B subunits in an attenuated strain of Salmonella typhimurium achieved protection in mice. Recently, the safety and immunogenicity of live recombinant Salmonella typhi vaccine expressing urease A and B from H. pylori in human volunteers has been tested with encouraging results.124

In summary, these immunization studies are very promising, but at the same time indicate that many problems are still unsolved: what constitutes the best antigen, the safest adjuvant and the best route of administration? In spite of these uncertainties, it is evident that childhood vaccination could, in theory, prevent one of the most diffuse chronic infections in the world, avoiding consistent morbidity in adult life, and reducing the incidence of gastric cancer later in life.

REFERENCES

  1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcerations. Lancet 1984; 1: 1311-1315.
  2. Windsor HM, O'Rourke J. Bacteriology and taxonomy of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29: 633-648.
  3. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
  4. International Agency for Research on Cancer. Monograph on the Evaluation of Carcinogenics Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer, 1994.
  5. Drumm B, Rhoads JM, Sringer DA et al. Peptic ulcer disease in children: etiology, clinical findings and clinical course. Pediatrics 1988; 82: 410-414.
  6. Eastham EJ. Peptic ulcer. In Walker WA, Durie P Hamilton JR et al, eds. Pediatric Gastrointestinal

Disease: Pathophysiology, Diagnosis, Management, vol 1. Philadelphia: BC Decker, 1991: 438-451. Nord KS, Rossi TM, Lebenthal E. Peptic ulcer in children: the predominance of gastric ulcers. Am J Gastroenterol 1981; 75: 153-157. Megraud F, Brassens-Rabbè MP, Denis F et al. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989; 27: 1870-1873.

Thomas JE, Dale A, Harding M et al. Helicobacter pylori colonization in early life. Pediatr Res 1999; 45: 218-223. De Giacomo C, Valdambrini V, Lizzoli F et al. A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents. Helicobacter 2002; 7: 356-363. Banatvala M, Mayo K, Megraud F et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-221.

  1. Fujisawa T, Kumagai T, Akamatsu T et al. Changes in sero-epidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 1999; 94: 2094-2099.
  2. Roosendaal R, Kuipers EJ, Buitenwerf J et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92: 1480-1482.
  3. Fiodorek SC, Malaty HM, Evans DL et al. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics 1991; 88: 578-582.
  4. Mendall MA, Goggin PM, Molineaux N et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-897.
  5. Malaty HM, El-Kasabany A, Graham DY et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002; 359: 931-935.
  6. Rowland M, Kumar D, Daly L et al. Low rates of Helicobacter pylori reinfection in children. Gastroenterology 1999; 117: 336-341.
  7. Klein PD, Gilman RH, Leon-Barua R et al. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol 1994; 89: 2196-2200.
  8. Parsonnet J, Blaser MJ, Perez-Perez GI et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41-46.
  9. Kuipers EJ, Pena AS, van Kamp G et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342: 328-331.
  10. Malaty HM, Engstrand L, Pederson NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences: a study of twins. Ann Intern Med 1994; 120: 982-986.
  11. De Giacomo C, Lisato L, Negrini R et al. Serum immune response to Helicobacter pylori in children: epidemio-logic end clinical applications. J Pediatr 1991; 119: 205-210.
  12. Buckley M, Mitchell HM, Bolin TD et al. Impact of institutionalization on prevalence of Helicobacter pylori infection. Gastroenterology 2001; 120: A735A735(abstract).
  13. Drumm B, Rowland M. The epidemiology of Helicobacter pylori: where to from here? J Pediatr Gastroenterol Nutr 2003; 36: 7-8.
  14. Nguyen AMH, Engstrand L, Genta RM et al. Detection of Helicobacter pylori in dental plaque by reverse tran-sciption-polymerase chain reaction. J Clin Microbiol 1993; 31: 783-787.
  15. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999; 282: 2240-2245.
  16. Klein P, Graham DY, Gaillour A et al. Water source as risk factor for Helicobacter pylori in Peruvian children. Lancet 1991; 337: 1503-1506.
  17. Thomas JE, Gibson GR, Darboe MK et al. Isolation of Helicobacter pylori from human feces. Lancet 1992; 340: 1194-1195.
  18. Marshall BJ, Goodwin CS, Warren JR et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-1442.
  19. Macarthur C, Saunders N, Feldman W. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA 1995; 273: 729-734.
  20. Oderda G, Forni M, Dell'Olio D, Ansaldi N. Cure of peptic ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1599.
  21. Mention K, Michaud L, Guimber D et al. Characteristics and prevalence of Helicobacter heilmannii infection in children undergoing upper gastrointestinal endoscopy. J Pediatr Gastroenterol Nutr 1999; 29: 533-539.
  22. Tomb JF, White O, Kerlavage AR et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388: 539-547. [Erratum, Nature 1997; 389: 412]
  23. Falush D, Kraft C, Taylor NS et al. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci USA 2001; 98: 15056-15061.
  24. Euler AR, Byrne WJ, Cousins LM et al. Increased serum gastrin concentrations and gastric acid hyposecretion in the immediate newborn period. Gastroenterology 1977; 72: 1271-1273.
  25. Euler AR, Byrne WJ, Meis PJ et al. Basal and pentagas-trin-stimulated acid secretion in newborn human infants. Pediat Res 1979; 13: 36-37.
  26. Agunod M, Yamaguchi N, Lopez R et al. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis 1969; 14: 400-414.
  27. Kopel FB, Barbero GJ. Gastric acid secretion in infancy and childhood. Gastroenterology 1967; 52: 1101.
  28. Christie DL, Ament ME. Gastric acid hypersecretion in children with duodenal ulcer. Gastroenterology 1976; 71: 242-244.
  29. Mohammed R, Hearns JB, Cream GP. Gastric acid secretion in children with duodenal ulceration. Scand J Gastroenterol 1982; 17: 289-292.
  30. Liebman WM. Gastric acid secretion and serum gastrin levels in children with recurrent abdominal pain, gastric and duodenal ulcers. J Clin Gastroenterol 1980; 2: 243-246.
  31. Tam PKH, Saing H. Gastric acid secretion and emptying rates in chidren with duodenal ulcer. J Pediatr Surg 1986; 21: 129-131.
  32. Christie DL, Ament ME. Gastrin response to a protein meal in children with duodenal ulcer. Pediatr Res 1976; 10: 353.
  33. De Giacomo C, Fiocca R, Villani L. Omeprazole treatment of severe peptic disease associated with antral G cell hyperfunction and hyperpepsinogenemia I in an infant. J Pediatr 1990; 117: 898-993.
  34. Habibullah CM, Alis MM, Ishaq M. Study of duodenal ulcer disease in 100 families using total serum pepsino-gen as a genetic marker. Gut 1984; 25: 1380-1383.
  35. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
  36. Mobley HLT. Helicobacter pylori urease. In Achtman M, Suerbaum S, eds. Helicobacter pylori: Molecular and Cellular Biology. Wymondham, UK: Horizon Scientific Press, 2001: 155-170.
  37. Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000; 287: 482-485.
  38. Ilver D, Arnqvist A, Ogren J et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373-377.
  39. Atherton JC, Cao P, Peek RM et al. Mosaicism in vacuolating citotoxin alleles of Helicobacter pylori. J Biol Chem 1995; 270: 17771-17777.
  40. Montecucco C, Papini E, de Bernard M et al. Helicobacter pylori VacA vacuolating cytotoxin and H. pylori-Nap neutrophil activating protein. In Achtman M, Suerbaum S, eds. Helicobacter pylori: Molecular and

Cellular Biology. Wymondham, UK: Horizon Scientific Press, 2001: 245-263.

Atherton JC, Peek RM Jr, Tham KT et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-99. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795.

Odenbreit S, Puls J, Sedlmaier B et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-1500. Crabtree JE. Mucosal immune responses to Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4(Suppl 2): S30-S32.

Naumann M, Wessler S, Bartsch C et al. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J Biol Chem 1999; 274: 31655-31662.

Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11-17.

Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter 1997; 2(Suppl 1): S13-S16. Oderda G, Vaira D, Holton J et al. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 1: 690-692. Queiroz DMM, Moura SB, Mendes EN et al. Effects of Helicobacter pylori eradication on G-cell and D-cell density in children. Lancet 1994; 343: 1191-1193. El-Omar EM, Penman IA, Ardill JES et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691.

Nord KS. Peptic ulcer. In Lebenthal E, ed. Textbook of

Pediatric Gastroenterology and Nutrition, 2nd edn. New

York: Raven Press, 1989: 815-827.

Murphy MS, Eastham EJ, Jimenez M et al. Duodenal ulceration: review of 110 cases. Arch Dis Child 1987; 62:

554-558.

Apley J, Naish N. Recurrent abdominal pains: a field survey of 1000 school children. Arch Dis Child 1958; 33: 165-170.

Hyams JS, Hyman PE. Recurrent abdominal pain and the biopsychosocial model of medical practice. J Pediatr 1998; 133: 473-478.

Czinn SJ, Dahms BB, Jacobs GH et al. Campylobacter-

like organisms in association with symptomatic gastritis in children. J Pediatr 1986; 109: 80-83.

Drumm B, Sherman P, Cutz E, Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987; 316:

1557-1561.

Oderda G, Holton J, Altare F et al. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 1: 690-693. De Giacomo C, Fiocca R, Villani L et al. Helicobacter pylori infection and chronic gastritis: clinical, serologi-cal, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate. J Pediatr Gastroenterol Nutr 1990; 11: 310-306. Glassman MS, Schwarz SM, Medow MS et al. Campylobacter pylori-related gastrointestinal disease in children. Incidence and clinical findings. Dig Dis Sci 1989; 34: 1501-1504.

  1. Blecker U, Hauser B, Lanciers S et al. Symptomatology of Helicobacter pylori infection in children. Acta Paediatr 1996; 85: 1156-1158.
  2. Mahony MJ, Wyatt JI, Littlewood JM. Management and response to treatment of Helicobacter pylori gastritis. Arch Dis Child 1992; 67: 940-943.
  3. Gormally SM, Prakash N, Durnin MT et al. Association of symptoms with Helicobacter pylori infection in children. J Pediatr 1995; 126: 753-756.
  4. O'Donohoe JM, Sullivan PB, Scott R et al. Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children. Acta Paediatr 1996; 85: 961-964.
  5. Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and abdominal symptoms: a population-based study among pre-school children in southern Germany. Pediatrics 1998; 101: 634-637.
  6. Rasquin-Weber A, Hyman PE, Cucchiara S et al. Childhood functional gastrointestinal disorders. Gut 1999; 45 (Suppl 2); II60-II68.
  7. Tucci A, Corinaldesi R, Stanghellini V et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768-774.
  8. Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology 2002; 122: 1521-1525.
  9. Sullivan PB, Thomas JE, Wight DG et al. Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child 1990; 65: 189-191.
  10. De Giacomo C, Fiocca R, Villani L et al. Barrett's ulcer and Campylobacter-like organisms infection in a child. J Pediatr Gastroenterol Nutr 1988; 7: 766-768.
  11. Hill P, Rode J. Helicobacter pylori in ectopic gastric mucosa in Meckel's diverticulum. Pathology 1998; 30: 7-9.
  12. Sherman P, Macarthur C. Current controversies associated with Helicobacter pylori infection in the pediatric population. Frontiers Biosci 2001; 6: e187-192.
  13. Barabino A, Dufour C, Marino CE. Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence. J Pediatr Gastroenterol Nutr 1999; 28: 116-119.
  14. Milman N, Rosenstock S, Andersen L et al. Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology 1998; 115: 274-278.
  15. Choe YH, Kwon YS, Jung MK et al. Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatr 2001; 139: 100-104.
  16. Patel P, Mendall MA, Khulusi S et al. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ 1994; 309: 1119-1123.
  17. Oderda G, Palli D, Saieva C et al. Short stature and Helicobacter pylori infection in italian children: prospective multicentre hospital based case-control study. The Italian Study Group on Short Stature and H. pylori. BMJ 1998; 317: 514-515.
  18. Kerr JR, Al-Khattaf A, Barson AJ, Burnie JP. An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection. Arch Dis Child 2000; 83: 429-434.
  19. Elitsur Y. Helicobacter pylori and SIDS: the jury is in at last! Am J Gastroenterol 2002; 97: 1576-1577.
  20. Dohil R, Hassal E, Jevon G, Dimmick J. Gastritis and gastropathy of childhood. J Pediatr Gastroenterol Nutr 1999; 29: 378-394.
  21. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996; 20: 161-81.
  22. Marshall BJ, Warren JR, Francis GJ et al. Rapid urease test in the management of Campylobacter pylori-associated gastritis. Am J Gastroenterol 1987; 82: 200-210.
  23. Luzza F, Oderda G, Maletta M et al. Salivary immunoglobulin G assay to diagnose Helicobacter pylori infection in children. J Clin Microbiol 1997; 35: 3358-3360.
  24. Oderda G, Rapa A, Ronchi B et al. Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ 2000; 320: 347-348.
  25. Ni Y-H, Lin J-T, Huang S-F et al. Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr 2000; 136: 823-827.
  26. Gold BD, Colletti RB, Abbott M et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. [Medical Position Papers: The North American Society for Pediatric Gastroenterology and Nutrition]. J Pediatr Gastroenterol Nutr 2000; 31: 490-497.
  27. Drumm B, Koletzko S, Oderda S, on behalf of the European Pediatric Task force on Helicobacter pylori. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000; 30: 207-213.
  28. Sherman P, Hassall E, Hunt RH et al. Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori infection in Children and Adolescents. Can J Gastroenterol 1999; 13: 553-559.
  29. Bazzoli F, Cecchini L, Corvaglia L et al. Validation of the 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a multicenter study. Am J Gastroenterol 2000; 95: 646-650.
  30. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180.
  31. Ganga-Zandzou PS, Michaud L, Vincent P et al. Natural outcome of Helicobacter pylori infection in asymptomatic children: a two-year follow-up study. Pediatrics 1999; 104: 216-222.
  32. Malfertheiner P, O' Connor HJ, Genta MR et al. Symposium: Helicobacter pylori and clinical risks -focus on gastro-esophageal reflux disease. Aliment Pharmacol Ther 2002; 16 (Suppl. 3): 1-10.
  33. Labenz J, Blum AL, Bayerdorffer E et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-1447.
  34. Moayyedi P, Bardhan C, Young L et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001; 121: 1120-1126.
  35. Wewer V, Andersen LP, Paerregaard A et al. Treatment of Helicobacter pylori in children with recurrent abdominal pain. Helicobacter 2001; 6: 244-248.
  36. Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther 2000; 14 (Suppl 3): 59-66.
  37. Gottrand F, Kalach N, Spyckerelle C et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial. J Pediatr 2001; 139: 664-668.
  38. Walsh D, Goggin N, Rowland M et al. One week treatment for Helicobacter pylori infection. Arch Dis Child 1997; 76: 352-355.
  39. Roggero P, Bonfiglio A, Luzzani S et al. Helicobacter pylori stool antigen test: a method to confirm eradication in children. J Pediatr 2002; 140: 775-777.
  40. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740.
  41. Woolf CM. A further study on the familial aspects of carcinoma of the stomach. Am J Hum Genet 1956; 8: 102-109.
  42. Huang J-Q, Sridhar S, Chen Y et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-1179.
  43. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
  44. Leung WK, Sung JJY. Intestinal metaplasia and gastric carcinogenesis. Aliment Pharm Ther 2002; 16: 1209-1216.
  45. Shiao YH, Rugge M, Correa P et al. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 511-517.
  46. Hansson LE, Nyren O, Hsing AW et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-249.
  47. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
  48. Forman D. Should we go further and screen and treat? Eur J Gastroenterol Hepatol 1999; 11(Suppl 2): S69-S71.
  49. Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-1271.
  50. Bayerdorffer E, Neubauer A, Rudolph B et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591-1594.
  51. Blecker U, McKeithan TW, Hart J, Kirschner BS. Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child. Gastroenterology 1995; 109: 973-977.
  52. Blanchard TG, Czinn SJ. Immunology of Helicobacter pylori and prospects for vaccine, Gastroenterol Clin North Am 2000; 29: 671-685.
  53. Michetti P, Kreiss C, Kotloff KL et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults, Gastroenterology 1999; 116: 804-812.
  54. Bumann D, Metzger WG, Mansouri E et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing a urease A and B from Helicobacter pylori in human volunteers Vaccine 2001; 20: 845-852.

Was this article helpful?

0 0
How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book


Post a comment